IndAS Details

Scrip Code	544647
NSE Symbol	NEPHROPLUS
MSEI Symbol	NOTLISTED
ISIN	INE428V01029
Name of company	Nephrocare Health Services Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-04-2025
Date of end of financial year	31-03-2026
Date of board meeting when results were approved	19-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	04-05-2026
Description of presentation currency	INR
Level of rounding used in financial results	Lakhs
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Healthcare
Start date and time of board meeting	19-05-2026 16:00:00
End date and time of board meeting	19-05-2026 17:15:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	19-05-2026
Indicate Company website link for updated RPT policy of the Company	https://nephroplus.com/api/assets/investors/disclosures-under-reg-46/policies-and-code-of-conduct/20260512_NephroPlus_Revised_RPT_policy_1.1.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	Yes
No. of times funds raised during the quarter	1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
No Default as on date.

Particulars	3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2026	01-04-2025
B	Date of end of reporting period	31-03-2026	31-03-2026
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
1	Income
	Revenue from operations	16,433.30	62,974.30
	Other income	613.50	1,543.40
	Total income	17,046.80	64,517.70
2	Expenses
(a)	Cost of materials consumed	4,101.20	16,073.20
(b)	Purchases of stock-in-trade	0.00	0.00
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	0.00	0.00
(d)	Employee benefit expense	3,215.50	12,108.60
(e)	Finance costs	127.20	4,976.10
(f)	Depreciation, depletion and amortisation expense	1,594.80	5,760.90
(f)	Other Expenses
1	Healthcare professional fees	2,087.70	8,265.30
2	Hospital fees	1,790.60	6,853.30
3	Other expenses	3,030.50	10,857.20
	Total other expenses	6,908.80	25,975.80
	Total expenses	15,947.50	64,894.60
3	Total profit before exceptional items and tax	1,099.30	(376.90)
4	Exceptional items	0.00	0.00
5	Total profit before tax	1,099.30	(376.90)
6	Tax expense
7	Current tax	390.60	1,412.00
8	Deferred tax	(380.10)	(982.90)
9	Total tax expenses	10.50	429.10
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0.00	0.00
11	Net Profit Loss for the period from continuing operations	1,088.80	(806.00)
12	Profit (loss) from discontinued operations before tax	0.00	0.00
13	Tax expense of discontinued operations	0.00	0.00
14	Net profit (loss) from discontinued operation after tax	0.00	0.00
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0.00	0.00
16	Total profit (loss) for period	1,088.80	(806.00)
17	Other comprehensive income net of taxes	8.20	5.10
18	Total Comprehensive Income for the period	1,097.00	(800.90)
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	2,006.80	2,006.80
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		0.00
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	1.09	-0.89
	Diluted earnings (loss) per share from continuing operations	1.06	-0.89
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	1.09	-0.89
	Diluted earnings (loss) per share from continuing and discontinued operations	1.06	-0.89
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results	Textual Information(1)

Textual Information(1)	1. The above standalone financial results of Nephrocare Health Services Limited (the Company) have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with the relevant rules thereunder, other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended). 2. These standalone financial results have been reviewed by the audit committee and approved by the Board of Directors in their respective meetings held on 19 May 2026. The above results have been subjected to audit by the statutory auditors of the Company. The statutory auditors have expressed an unmodified audit opinion on these results. 3. The Company is primarily engaged in business of providing dialysis and sale of related healthcare services and products which is considered to be the only reportable segment as per Ind AS 108, 'Operating Segments'. Segment Disclosure Particulars Quarter ended Year ended 31 March 2026 31 December 2025 31 March 2025 31 March 2026 31 March 2025 Segment Revenue: Revenue from operations 1,643.33 1,606.64 1,450.12 6,297.43 5,435.97 Segment Results: Profit/(loss) before tax 109.93 89.57 74.16 (37.69) 453.60 Segment assets: Total assets 11,350.51 12,066.59 7,566.10 11,350.51 7,566.10 Segment liabilities: Total liabilities 1,641.45 2,200.20 2,146.02 1,641.45 2,146.02 4. The standalone figures for the quarter ended 31 March 2026 are the balancing figures between the audited standalone figures in respect of the full financial year and the published unaudited year to date standalone figures up to the third quarter of the current financial year. The standalone figures for the quarter ended 31 March 2025 are the balancing figures between the audited standalone figures in respect of the full financial year and the unaudited management accounts year to date standalone figures up to the third quarter of the previous financial year. 5. During the year ended 31 March 2026, the Company has completed an initial public offering (IPO) of 18,943,020 equity shares with a face value of INR 2 each at an issue price of INR 460 per share, comprising fresh issue of 7,689,918 shares and an offer for sale of 11,253,102 shares. The Company’s equity shares were listed on the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on 17 December 2025. The utilisation of net IPO proceeds is summarised below: (Amounts in INR millions) Objectives Amount to be utilised as per prospectus Utilisation up to 31 March 2026 Unutilised as on 31 March 2026 Capital expenditure by our Company for opening new dialysis clinics in India 1,291.06 37.22 1,253.84 Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by our Company 1,359.99 1,359.99 - General corporate purposes 600.48 218.69 381.79 Total 3,251.53 1,615.90 1,635.63 6. During the year ended 31 March 2026, the Company incurred interest expense on financial liabilities measured at fair value through profit or loss (FVTPL) aggregating to INR371.89 million. The said item is non-cash and non-recurring nature and the impact has been presented under “Finance costs” in the statement of standalone financial results. 7. The results for quarter and year ended 31 March 2026, are available on the BSE Limited website (URL: www.bseindia.com), the National Stock Exchange of India Limited website (URL: nseindia.com) and on the Company's website (URL: https://nephroplus.com/investors).

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Particulars	Year ended (dd-mm-yyyy)
Date of start of reporting period	01-04-2025
Date of end of reporting period	31-03-2026
Whether results are audited or unaudited	Audited
Nature of report standalone or consolidated	Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	24,273.10
	Capital work-in-progress	350.60
	Investment property	0.00
	Goodwill	0.00
	Other intangible assets	204.70
	Intangible assets under development	0.00
	Biological assets other than bearer plants	23.70
	Investments accounted for using equity method	0.00
	Non-current financial assets
	Non-current investments	16,468.40
	Trade receivables, non-current	0.00
	Loans, non-current	0.00
	Other non-current financial assets
1	Other non-current financial assets	4,144.30
	Total of other non-current financial assets	4,144.30
	Total non-current financial assets	20,612.70
	Deferred tax assets (net)	2,779.60
	Other non-current assets
1	Other non-current assets	988.50
	Total of other non-current assets	988.50
	Total non-current assets	49,232.90
2	Current assets
	Inventories	1,812.80
	Current financial asset
	Current investments	17,064.10
	Trade receivables, current	21,766.30
	Cash and cash equivalents	9,367.80
	Bank balance other than cash and cash equivalents	13,157.30
	Loans, current	0.00
	Other current financial assets
	Total of other current financial assets	761.40
	Total current financial assets	62,116.90
	Current tax assets (net)	0.00
	Other current assets
1	Other current assets	342.50
	Total of other current assets	342.50
	Total current assets	64,272.20
3	Non-current assets classified as held for sale	0.00
4	Regulatory deferral account debit balances and related deferred tax Assets	0.00
	Total assets	1,13,505.10
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	2,006.80
	Other equity	95,083.80
	Total equity attributable to owners of parent	97,090.60
	Non controlling interest
	Total equity	97,090.60
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	721.00
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0.00
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0.00
	Total Trade payable	0.00
	Other non-current financial liabilities
1	Other non-current financial liabilities	43.40
	Total of other non-current financial liabilities	43.40
	Total non-current financial liabilities	764.40
	Provisions, non-current	585.70
	Deferred tax liabilities (net)	0.00
	Deferred government grants, Non-current	0.00
	Other non-current liabilities
1	Other non-current liabilities	0.00
	Total of other non-current liabilities	0.00
	Total non-current liabilities	1,350.10
	Current liabilities
	Current financial liabilities
	Borrowings, current	450.70
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	1,563.50
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	6,896.70
	Total Trade payable	8,460.20
	Other current financial liabilities
1	Other current financial liabilities	5,627.30
	Total of other current financial liabilities	5,627.30
	Total current financial liabilities	14,538.20
	Other current liabilities	334.00
1	Other current liabilities	334.00
	Total of other current liabilities	334.00
	Provisions, current	192.20
	Current tax liabilities (Net)	0.00
	Deferred government grants, Current	0.00
	Total current liabilities	15,064.40
3	Liabilities directly associated with assets in disposal group classified as held for sale	0.00
4	Regulatory deferral account credit balances and related deferred tax liability	0.00
	Total liabilities	16,414.50
	Total equity and liabilites	1,13,505.10
	Disclosure of notes on assets and liabilities

Particulars	3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period	01-01-2026	01-04-2025
Date of end of reporting period	31-03-2026	31-03-2026
Whether results are audited or unaudited	Audited	Audited
Nature of report standalone or consolidated	Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Particulars	3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2026	01-04-2025
B	Date of end of reporting period	31-03-2026	31-03-2026
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurement gains/(loss) on defined benefit plans	10.90	6.80
2	Tax on remeasurement gains/(loss) on defined benefit plans	(2.70)	(1.70)
	Total Amount of items that will not be reclassified to profit and loss	8.20	5.10
2	Income tax relating to items that will not be reclassified to profit or loss	0.00	0.00
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0.00	0.00
5	Total Other comprehensive income	8.20	5.10

Particulars	Year ended (dd-mm-yyyy)
A	Date of start of reporting period	01-04-2025
B	Date of end of reporting period	31-03-2026
C	Whether results are audited or unaudited	Audited
D	Nature of report standalone or consolidated	Standalone
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax	(376.90)
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs	4,976.10
	Adjustments for decrease (increase) in inventories	(55.00)
	Adjustments for decrease (increase) in trade receivables, current	(3,728.80)
	Adjustments for decrease (increase) in trade receivables, non-current	0.00
	Adjustments for decrease (increase) in other current assets	83.70
	Adjustments for decrease (increase) in other non-current assets	0.00
	Adjustments for other financial assets, non-current	0.00
	Adjustments for other financial assets, current	(293.10)
	Adjustments for other bank balances	0.00
	Adjustments for increase (decrease) in trade payables, current	2,261.20
	Adjustments for increase (decrease) in trade payables, non-current	0.00
	Adjustments for increase (decrease) in other current liabilities	(41.60)
	Adjustments for increase (decrease) in other non-current liabilities	0.00
	Adjustments for depreciation and amortisation expense	5,760.90
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss	0.00
	Adjustments for provisions, current	148.60
	Adjustments for provisions, non-current	0.00
	Adjustments for other financial liabilities, current	4,960.70
	Adjustments for other financial liabilities, non-current	0.00
	Adjustments for unrealised foreign exchange losses gains	0.00
	Adjustments for dividend income	0.00
	Adjustments for interest income	568.10
	Adjustments for share-based payments	918.30
	Adjustments for fair value losses (gains)	(643.80)
	Adjustments for undistributed profits of associates	0.00
	Other adjustments for which cash effects are investing or financing cash flow	0.00
	Other adjustments to reconcile profit (loss)	0.00
	Other adjustments for non-cash items	1,674.60
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships	0.00
	Total adjustments for reconcile profit (loss)	15,453.70
	Net cash flows from (used in) operations	15,076.80
	Dividends received	0.00
	Interest paid	0.00
	Interest received	0.00
	Income taxes paid (refund)	1,786.60
	Other inflows (outflows) of cash	0.00
	Net cash flows from (used in) operating activities	13,290.20
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses	0.00
	Cash flows used in obtaining control of subsidiaries or other businesses	308.60
	Other cash receipts from sales of equity or debt instruments of other entities	0.00
	Other cash payments to acquire equity or debt instruments of other entities	0.00
	Other cash receipts from sales of interests in joint ventures	0.00
	Other cash payments to acquire interests in joint ventures	0.00
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships	0.00
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships	0.00
	Proceeds from sales of property, plant and equipment	21.60
	Purchase of property, plant and equipment	7,620.20
	Proceeds from sales of investment property	0.00
	Purchase of investment property	0.00
	Proceeds from sales of intangible assets	0.00
	Purchase of intangible assets	24.80
	Proceeds from sales of intangible assets under development	0.00
	Purchase of intangible assets under development	0.00
	Proceeds from sales of goodwill	0.00
	Purchase of goodwill	0.00
	Proceeds from biological assets other than bearer plants	0.00
	Purchase of biological assets other than bearer plants	0.00
	Proceeds from government grants	0.00
	Proceeds from sales of other long-term assets	0.00
	Purchase of other long-term assets	0.00
	Cash advances and loans made to other parties	0.00
	Cash receipts from repayment of advances and loans made to other parties	0.00
	Cash payments for future contracts, forward contracts, option contracts and swap contracts	0.00
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts	0.00
	Dividends received	0.00
	Interest received	425.30
	Income taxes paid (refund)	0.00
	Other inflows (outflows) of cash	(22,368.50)
	Net cash flows from (used in) investing activities	(29,875.20)
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries	0.00
	Payments from changes in ownership interests in subsidiaries	0.00
	Proceeds from issuing shares	39,020.50
	Proceeds from issuing other equity instruments	0.00
	Payments to acquire or redeem entity's shares	0.00
	Payments of other equity instruments	0.00
	Proceeds from exercise of stock options	0.00
	Proceeds from issuing debentures notes bonds etc	0.00
	Proceeds from borrowings	0.00
	Repayments of borrowings	12,000.90
	Payments of lease liabilities	294.10
	Dividends paid	0.00
	Interest paid	1,158.10
	Income taxes paid (refund)	0.00
	Other inflows (outflows) of cash	0.00
	Net cash flows from (used in) financing activities	25,567.40
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes	8,982.40
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents	0.00
	Net increase (decrease) in cash and cash equivalents	8,982.40
	Cash and cash equivalents cash flow statement at beginning of period	385.40
	Cash and cash equivalents cash flow statement at end of period	9,367.80

Whether results are audited or unaudited	Audited
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results	Yes

Sr No.	Audit firm's name	Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI	Certificate valid upto
1	M/s. B S R and Co, Chartered Accountants	Yes	30-04-2029

Mode of Fund Raising	Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds	17-12-2025
Amount Raised	35,340.50
Report filed for Quarter ended	31-03-2026
Monitoring Agency	Applicable
Monitoring Agency Name, if applicable	Crisil Ratings Limited
Is there a Deviation / Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review
Comments of the auditors, if any

	Name	Name	Relationship of the counterparty with the listed entity or its subsidiary	Type of related party transaction	Details of other related party transaction		Remarks on approval by audit committee			Value of transaction during the reporting period	Opening balance	Closing balance	Nature of indebtedness (loan/ issuance of debt/ any other etc.)	Details of other indebtedness	Nature (loan/ advance/ intercorporate deposit/ investment )	Notes
Sr No.														Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
	Details of the party (listed entity/subsidiary) entering into the transaction	Details of the counterparty		Type of related party transaction	Details of other related party transaction	Value of the related party transaction as approved by the audit committee	Remarks on approval by audit committee	Value of the related party transaction ratified by the audit committee	Date of Audit Committee Meeting where the ratification was approved	Value of transaction during the reporting period	In case monies are due to either party as a result of the transaction		In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments		Details of the loans, inter-corporate deposits, advances or investments	Notes
1	Nephrocare Health Services Limited (“NephroPlus”)	Vikram Vuppala	Chairman & Managing Director	Remuneration			NA			129.20	12.60	191.70
2	NephroPlus	Rohit Singh	Chief Executive Officer	Remuneration			NA			55.60	5.60	50.30
3	NephroPlus	Prashant VinodKumar Goenka	Chief Financial Officer	Remuneration			NA			86.80	7.40	45.00
4	NephroPlus	Kishore Kathri	Company Secretary (appointed w.e.f 16th July, 2025)	Remuneration			NA			16.50	2.10	8.80
5	NephroPlus	Om Prakash Manchanda	Independent Director	Any other transaction	Directors’ sitting fees		NA			11.50	11.60	3.00
6	NephroPlus	Hemant Sultania	Independent Director	Any other transaction	Directors’ sitting fees		NA			13.00	11.60	3.00
7	NephroPlus	Annette Kumlien	Independent Director	Any other transaction	Directors’ sitting fees		NA			13.00	11.70	4.00
8	NephroPlus	Ajay Bakshi	Independent Director	Any other transaction	Directors’ sitting fees		NA			11.50	11.90	6.00
9	NephroPlus	Annette Kumlien	Independent Director	Any other transaction	Reimbursement of Expenses		NA			0.40	0.00	0.00
10	NephroPlus	Achala Health Services Private Limited(AHSPL)	Mr. Vikram Vuppala, Promoter and Chairman & Managing Director is member of AHSPL holding 600 equity shares	Purchase of goods or services		500.00	Approved			54.60	0.00	0.00
11	NephroPlus	Neuranceai Technologies Private Limited (NTPL)	Mr. Ajay Bakshi, Independent Director is a Director of NTPL.	Purchase of goods or services		50.00	Approved			13.10	0.00	0.00
12	NephroPlus	Nephrocare Health Services Central Asia	Wholly owned subsidiary	Any other transaction	Royalty		NA			329.70	0.00	0.00
13	NephroPlus	Nephrocare Health Care Services, Philippines Inc.	Step down subsidiary	Any other transaction	Royalty		NA			450.90	0.00	0.00
14	NephroPlus	AIZ Hemodialysis Centre Inc.	Step down subsidiary	Any other transaction	Royalty		NA			7.50	0.00	0.00
15	NephroPlus	Anram Medical Group Inc.	Step down subsidiary	Any other transaction	Royalty		NA			17.00	0.00	0.00
16	NephroPlus	Bioregen Hemo Center Inc.	Step down subsidiary	Any other transaction	Royalty		NA			13.00	0.00	0.00
17	NephroPlus	Cadiz Dialysis Hub Inc.	Step down subsidiary	Any other transaction	Royalty		NA			28.40	0.00	0.00
18	NephroPlus	Carmona Dialysis System Inc.	Step down subsidiary	Any other transaction	Royalty		NA			19.30	0.00	0.00
19	NephroPlus	Curis Cavite Renal Corporation	Step down subsidiary	Any other transaction	Royalty		NA			30.60	0.00	0.00
20	NephroPlus	Curis Hemodialysis Clinic Inc.	Step down subsidiary	Any other transaction	Royalty		NA			20.60	0.00	0.00
21	NephroPlus	Infini Care Health Systems Inc.	Step down subsidiary	Any other transaction	Royalty		NA			11.50	0.00	0.00
22	NephroPlus	Kolff Dialysis Inc.	Step down subsidiary	Any other transaction	Royalty		NA			34.90	0.00	0.00
23	NephroPlus	Medical Experts Group and Associates Inc.	Step down subsidiary	Any other transaction	Royalty		NA			23.10	0.00	0.00
24	NephroPlus	Mega Health Dialysis Center Inc.	Step down subsidiary	Any other transaction	Royalty		NA			17.40	0.00	0.00
25	NephroPlus	Nephro Alliance ventures Inc	Step down subsidiary	Any other transaction	Royalty		NA			35.20	0.00	0.00
26	NephroPlus	People's Center For Hemodialysis Care Inc.	Step down subsidiary	Any other transaction	Royalty		NA			25.90	0.00	0.00
27	NephroPlus	Renal Therapy Solutions Inc	Step down subsidiary	Any other transaction	Royalty		NA			222.20	0.00	0.00
28	NephroPlus	Rizal dialysis and wellness centre OPC	Step down subsidiary	Any other transaction	Royalty		NA			20.90	0.00	0.00
29	NephroPlus	Universe Dialysis and Kidney Care Center Inc.	Step down subsidiary	Any other transaction	Royalty		NA			18.50	0.00	0.00
30	NephroPlus	Nephrocare Health Services Nepal Pvt Ltd	Wholly owned subsidiary	Any other transaction	Royalty		NA			34.10	0.00	0.00
31	NephroPlus	Nephrocare Health Services Central Asia	Wholly owned subsidiary	Any other transaction	Referral fee		NA			549.30	0.00	0.00
32	NephroPlus	Nephrocare Health Services Central Asia	Wholly owned subsidiary	Any other transaction	Guarantee Commission		NA			5.10	0.00	0.00
33	NephroPlus	Nephrocare Health Care Services, Philippines Inc.	Step down subsidiary	Any other transaction	Guarantee Commission		NA			4.50	0.00	0.00
34	NephroPlus	Nephrocare Health Services Nepal Pvt Ltd	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			43.10	0.00	0.00
35	NephroPlus	Nephrocare Health Services Nepal Pvt Ltd	Wholly owned subsidiary	Any other transaction	Sale of PPE		NA			531.40	0.00	0.00
36	NephroPlus	Nephrocare Health Services Nepal Pvt Ltd	Wholly owned subsidiary	Any other transaction	Investment in subsidiary		NA			183.60	0.00	0.00
37	NephroPlus	Nephrocare Health Care Services, Philippines Inc.	Step down subsidiary	Any other transaction	Management expenses		NA			504.10	0.00	0.00
38	NephroPlus	Nephrocare Health Services Central Asia	Wholly owned subsidiary	Any other transaction	Management expenses		NA			141.90	0.00	0.00
39	NephroPlus	Nephrocare Health Services International Pte, Singapore	Wholly owned subsidiary	Any other transaction	Management expenses		NA			1.00	0.00	0.00
40	NephroPlus	Nephrocare Health Services Nepal Pvt Ltd	Wholly owned subsidiary	Any other transaction	Management expenses		NA			31.50	0.00	0.00
41	NephroPlus	Nephrocare Health Care Services, Philippines Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	1,824.30	168.60
42	NephroPlus	AIZ Hemodialysis Centre Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	8.50	5.50
43	NephroPlus	Anram Medical Group Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	77.30	0.00
44	NephroPlus	Bioregen Hemo Center Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	16.50	9.50
45	NephroPlus	Cadiz Dialysis Hub Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	74.20	20.10
46	NephroPlus	Carmona Dialysis System Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	24.20	13.60
47	NephroPlus	Curis Cavite Renal Corporation	Step down subsidiary	Any other transaction	Receivables		NA			0.00	72.40	21.40
48	NephroPlus	Curis Hemodialysis Clinic Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	51.40	14.80
49	NephroPlus	Dialysis Asia and Patient Care Center Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	46.60	0.00
50	NephroPlus	Infini Care Health Systems Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	13.40	7.80
51	NephroPlus	Kolff Dialysis Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	34.00	25.50
52	NephroPlus	Medical Experts Group and Associates Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	73.20	15.80
53	NephroPlus	Mega Health Dialysis Center Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	44.30	11.80
54	NephroPlus	Nephro Alliance Ventures Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	33.60	24.40
55	NephroPlus	People's Center For Hemodialysis Care Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	57.90	17.90
56	NephroPlus	Renal Therapy Solutions Inc	Step down subsidiary	Any other transaction	Receivables		NA			0.00	479.50	154.10
57	NephroPlus	Rizal dialysis and wellness centre OPC	Step down subsidiary	Any other transaction	Receivables		NA			0.00	45.60	14.70
58	NephroPlus	St. Margareth Dialysis and Biocare Center Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	43.20	0.00
59	NephroPlus	Universe Dialysis and Kidney Care Center Inc.	Step down subsidiary	Any other transaction	Receivables		NA			0.00	70.80	10.40
60	NephroPlus	Nephrocare Health Services Nepal Pvt Ltd	Wholly owned subsidiary	Any other transaction	Receivables		NA			0.00	0.00	641.20
61	NephroPlus	Nephrocare Health Services Saudi Arabia	Step down subsidiary	Any other transaction	Receivables		NA			0.00	(0.90)	0.00
62	NephroPlus	Nephrocare Health Services International Pte, Singapore	Wholly owned subsidiary	Any other transaction	Receivables		NA			0.00	(4.30)	0.00
63	NephroPlus	Nephrocare Health Services Central Asia	Wholly owned subsidiary	Any other transaction	Receivables		NA			0.00	1,030.90	186.60
64	NephroPlus	Nephrocare Health Services International Pte, Singapore	Holding company	Any other transaction	Reimbursement of expenses		NA			5.20	0.00	0.00
65	NephroPlus	Nephrocare Health Services Central Asia	Holding company	Any other transaction	Reimbursement of expenses		NA			38.20	0.00	0.00
66	NephroPlus	Nephrocare Health Services Saudi Arabia	Joint venture	Any other transaction	Reimbursement of expenses		NA			1.10	0.00	0.00
67	Bioregen Hemo Center Inc.	Infini Care Health Systems Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.10	0.00	0.00
68	Bioregen Hemo Center Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.10	0.00	0.00
69	Cadiz Dialysis Hub Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.20	0.00	0.00
70	Cadiz Dialysis Hub Inc.	Renal Therapy Solutions Inc	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.60	0.00	0.00
71	Carmona Dialysis System Inc.	Kolff Dialysis Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.60	0.00	0.00
72	Carmona Dialysis System Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.00	0.00	0.00
73	Curis Cavite Renal Corporation	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			2.10	0.00	0.00
74	Curis Hemodialysis Clinic Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			1.00	0.00	0.00
75	Infini Care Health Systems Inc.	Bioregen Hemo Center Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.10	0.00	0.00
76	Infini Care Health Systems Inc.	Renal Therapy Solutions Inc	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.00	0.00	0.00
77	Medical Experts Group and Associates Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.70	0.00	0.00
78	Medical Experts Group and Associates Inc.	People's Center for Hemodialysis Care Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.90	0.00	0.00
79	Medical Experts Group and Associates Inc.	Renal Therapy Solutions Inc	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.70	0.00	0.00
80	Mega Health Dialysis Center Inc.	Kolff Dialysis Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.10	0.00	0.00
81	Mega Health Dialysis Center Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.20	0.00	0.00
82	Mega Health Dialysis Center Inc.	Renal Therapy Solutions Inc	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.00	0.00	0.00
83	Mega Health Dialysis Center Inc.	Universe Dialysis and Kidney Care Center Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.30	0.00	0.00
84	Nephrocare Health Care Services, Philippines Inc.	AIZ Hemodialysis Centre Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			10.60	0.00	0.00
85	Nephrocare Health Care Services, Philippines Inc.	Anram Medical Group Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			1.30	0.00	0.00
86	Nephrocare Health Care Services, Philippines Inc.	Bioregen Hemo Center Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			13.90	0.00	0.00
87	Nephrocare Health Care Services, Philippines Inc.	Cadiz Dialysis Hub Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			21.50	0.00	0.00
88	Nephrocare Health Care Services, Philippines Inc.	Carmona Dialysis System Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			21.60	0.00	0.00
89	Nephrocare Health Care Services, Philippines Inc.	Curis Cavite Renal Corporation	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			33.70	0.00	0.00
90	Nephrocare Health Care Services, Philippines Inc.	Curis Hemodialysis Clinic Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			20.50	0.00	0.00
91	Nephrocare Health Care Services, Philippines Inc.	Infini Care Health Systems Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			15.10	0.00	0.00
92	Nephrocare Health Care Services, Philippines Inc.	Kolff Dialysis Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			40.10	0.00	0.00
93	Nephrocare Health Care Services, Philippines Inc.	Medical Experts Group and Associates Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			28.20	0.00	0.00
94	Nephrocare Health Care Services, Philippines Inc.	Mega Health Dialysis Center Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			14.90	0.00	0.00
95	Nephrocare Health Care Services, Philippines Inc.	Nephro Alliance ventures Inc	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			25.90	0.00	0.00
96	Nephrocare Health Care Services, Philippines Inc.	People's Center for Hemodialysis Care Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			29.60	0.00	0.00
97	Nephrocare Health Care Services, Philippines Inc.	Renal Therapy Solutions Inc	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			158.60	0.00	0.00
98	Nephrocare Health Care Services, Philippines Inc.	Rizal dialysis and wellness centre OPC	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			14.90	0.00	0.00
99	Nephrocare Health Care Services, Philippines Inc.	St. Margareth Dialysis and Biocare Center Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			0.00	0.00	0.00
100	Nephrocare Health Care Services, Philippines Inc.	Universe Dialysis and Kidney Care Center Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			15.70	0.00	0.00
101	People's Center for Hemodialysis Care Inc.	Medical Experts Group and Associates Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.00	0.00	0.00
102	People's Center for Hemodialysis Care Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.10	0.00	0.00
103	Renal Therapy Solutions Inc	Cadiz Dialysis Hub Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			1.20	0.00	0.00
104	Renal Therapy Solutions Inc	Medical Experts Group and Associates Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.30	0.00	0.00
105	Renal Therapy Solutions Inc	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			1.10	0.00	0.00
106	Rizal dialysis and wellness centre OPC	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.50	0.00	0.00
107	Universe Dialysis and Kidney Care Center Inc.	Mega Health Dialysis Center Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.00	0.00	0.00
108	Universe Dialysis and Kidney Care Center Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.10	0.00	0.00
109	AIZ Hemodialysis Centre Inc.	Universe Dialysis and Kidney Care Center Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.20	0.00	0.00
110	Anram Medical Group Inc.	Medical Experts Group and Associates Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.70	0.00	0.00
111	Anram Medical Group Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			2.20	0.00	0.00
112	Anram Medical Group Inc.	People's Center for Hemodialysis Care Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.70	0.00	0.00
113	Anram Medical Group Inc.	Renal Therapy Solutions Inc	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.80	0.00	0.00
114	Bioregen Hemo Center Inc.	Infini Care Health Systems Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.50	0.00	0.00
115	Curis Cavite Renal Corporation	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.30	0.00	0.00
116	Cadiz Dialysis Hub Inc.	Renal Therapy Solutions Inc	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.30	0.00	0.00
117	Curis Hemodialysis Clinic Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			1.60	0.00	0.00
118	Infini Care Health Systems Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.00	0.00	0.00
119	Medical Experts Group and Associates Inc.	Anram Medical Group Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.10	0.00	0.00
120	Medical Experts Group and Associates Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			4.50	0.00	0.00
121	Medical Experts Group and Associates Inc.	Renal Therapy Solutions Inc	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.00	0.00	0.00
122	Mega Health Dialysis Center Inc.	Carmona Dialysis System Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.10	0.00	0.00
123	Mega Health Dialysis Center Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.20	0.00	0.00
124	Nephro Alliance ventures Inc	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			37.40	0.00	0.00
125	Nephrocare Health Care Services, Philippines Inc.	AIZ Hemodialysis Centre Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			5.80	0.00	0.00
126	Nephrocare Health Care Services, Philippines Inc.	Anram Medical Group Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			42.20	0.00	0.00
127	Nephrocare Health Care Services, Philippines Inc.	Bioregen Hemo Center Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			9.10	0.00	0.00
128	Nephrocare Health Care Services, Philippines Inc.	Cadiz Dialysis Hub Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			17.30	0.00	0.00
129	Nephrocare Health Care Services, Philippines Inc.	Carmona Dialysis System Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			19.40	0.00	0.00
130	Nephrocare Health Care Services, Philippines Inc.	Curis Cavite Renal Corporation	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			28.70	0.00	0.00
131	Nephrocare Health Care Services, Philippines Inc.	Curis Hemodialysis Clinic Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			14.00	0.00	0.00
132	Nephrocare Health Care Services, Philippines Inc.	Infini Care Health Systems Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			9.40	0.00	0.00
133	Nephrocare Health Care Services, Philippines Inc.	Kolff Dialysis Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			28.00	0.00	0.00
134	Nephrocare Health Care Services, Philippines Inc.	Medical Experts Group and Associates Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			28.70	0.00	0.00
135	Nephrocare Health Care Services, Philippines Inc.	Mega Health Dialysis Center Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			15.70	0.00	0.00
136	Nephrocare Health Care Services, Philippines Inc.	Nephro Alliance ventures Inc	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			8.20	0.00	0.00
137	Nephrocare Health Care Services, Philippines Inc.	People's Center for Hemodialysis Care Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			28.90	0.00	0.00
138	Nephrocare Health Care Services, Philippines Inc.	Renal Therapy Solutions Inc	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			163.40	0.00	0.00
139	Nephrocare Health Care Services, Philippines Inc.	Rizal dialysis and wellness centre OPC	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			15.40	0.00	0.00
140	Nephrocare Health Care Services, Philippines Inc.	Universe Dialysis and Kidney Care Center Inc.	Wholly owned subsidiary	Any other transaction	Sale of Consumables		NA			16.20	0.00	0.00
141	People's Center for Hemodialysis Care Inc.	Anram Medical Group Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.50	0.00	0.00
142	People's Center for Hemodialysis Care Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.30	0.00	0.00
143	Rizal dialysis and wellness centre OPC	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			7.40	0.00	0.00
144	Rizal dialysis and wellness centre OPC	Renal Therapy Solutions Inc	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.00	0.00	0.00
145	Renal Therapy Solutions Inc	Anram Medical Group Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.20	0.00	0.00
146	Renal Therapy Solutions Inc	Cadiz Dialysis Hub Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			1.30	0.00	0.00
147	Renal Therapy Solutions Inc	Medical Experts Group and Associates Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.10	0.00	0.00
148	Renal Therapy Solutions Inc	Nephro Alliance ventures Inc	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			0.80	0.00	0.00
149	Renal Therapy Solutions Inc	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			2.40	0.00	0.00
150	Renal Therapy Solutions Inc	People's Center for Hemodialysis Care Inc.	Fellow subsidiary	Any other transaction	Sale of Consumables		NA			2.60	0.00	0.00
151	Anram Medical Group Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of PPE -ATA		NA			202.10	0.00	0.00
152	Anram Medical Group Inc.	Nephrocare Health Care Services, Philippines Inc.	Fellow subsidiary	Any other transaction	Sale of Inventory -ATA		NA			13.90	0.00	0.00
153	Nephrocare Health Care Services, Philippines Inc.	AIZ Hemodialysis Centre Inc.	Wholly owned subsidiary	Any other transaction	Management expenses		NA			12.70	0.00	0.00
154	Nephrocare Health Care Services, Philippines Inc.	Anram Medical Group Inc.	Wholly owned subsidiary	Any other transaction	Management expenses		NA			26.90	0.00	0.00
155	Nephrocare Health Care Services, Philippines Inc.	Bioregen Hemo Center Inc.	Wholly owned subsidiary	Any other transaction	Management expenses		NA			22.10	0.00	0.00
156	Nephrocare Health Care Services, Philippines Inc.	Cadiz Dialysis Hub Inc.	Wholly owned subsidiary	Any other transaction	Management expenses		NA			47.50	0.00	0.00
157	Nephrocare Health Care Services, Philippines Inc.	Carmona Dialysis System Inc.	Wholly owned subsidiary	Any other transaction	Management expenses		NA			32.10	0.00	0.00
158	Nephrocare Health Care Services, Philippines Inc.	Curis Cavite Renal Corporation	Wholly owned subsidiary	Any other transaction	Management expenses		NA			50.90	0.00	0.00
159	Nephrocare Health Care Services, Philippines Inc.	Curis Hemodialysis Clinic Inc.	Wholly owned subsidiary	Any other transaction	Management expenses		NA			35.00	0.00	0.00
160	Nephrocare Health Care Services, Philippines Inc.	Infini Care Health Systems Inc.	Wholly owned subsidiary	Any other transaction	Management expenses		NA			19.30	0.00	0.00
161	Nephrocare Health Care Services, Philippines Inc.	Kolff Dialysis Inc.	Wholly owned subsidiary	Any other transaction	Management expenses		NA			59.10	0.00	0.00
162	Nephrocare Health Care Services, Philippines Inc.	Medical Experts Group and Associates Inc.	Wholly owned subsidiary	Any other transaction	Management expenses		NA			38.20	0.00	0.00
163	Nephrocare Health Care Services, Philippines Inc.	Mega Health Dialysis Center Inc.	Wholly owned subsidiary	Any other transaction	Management expenses		NA			29.10	0.00	0.00
164	Nephrocare Health Care Services, Philippines Inc.	Nephro Alliance ventures Inc	Wholly owned subsidiary	Any other transaction	Management expenses		NA			58.30	0.00	0.00
165	Nephrocare Health Care Services, Philippines Inc.	People's Center for Hemodialysis Care Inc.	Wholly owned subsidiary	Any other transaction	Management expenses		NA			43.20	0.00	0.00
166	Nephrocare Health Care Services, Philippines Inc.	Renal Therapy Solutions Inc	Wholly owned subsidiary	Any other transaction	Management expenses		NA			370.40	0.00	0.00
167	Nephrocare Health Care Services, Philippines Inc.	Rizal dialysis and wellness centre OPC	Wholly owned subsidiary	Any other transaction	Management expenses		NA			35.10	0.00	0.00
168	Nephrocare Health Care Services, Philippines Inc.	Universe Dialysis and Kidney Care Center Inc.	Wholly owned subsidiary	Any other transaction	Management expenses		NA			30.80	0.00	0.00
169	Nephrocare Health Care Services, Philippines Inc.	Anram Medical Group Inc.	Wholly owned subsidiary	Any other transaction	Dividend		NA			349.70	0.00	0.00
170	Nephrocare Health Care Services, Philippines Inc.	Curis Cavite Renal Corporation	Wholly owned subsidiary	Any other transaction	Dividend		NA			412.30	0.00	0.00
171	Nephrocare Health Care Services, Philippines Inc.	Cadiz Dialysis Hub Inc.	Wholly owned subsidiary	Any other transaction	Dividend		NA			274.90	0.00	0.00
172	Nephrocare Health Care Services, Philippines Inc.	Curis Hemodialysis Clinic Inc.	Wholly owned subsidiary	Any other transaction	Dividend		NA			18.30	0.00	0.00
173	Nephrocare Health Care Services, Philippines Inc.	Dialysis Asia and Patient Care Center Inc.	Wholly owned subsidiary	Any other transaction	Dividend		NA			229.10	0.00	0.00
174	Nephrocare Health Care Services, Philippines Inc.	Medical Experts Group and Associates Inc.	Wholly owned subsidiary	Any other transaction	Dividend		NA			129.80	0.00	0.00
175	Nephrocare Health Care Services, Philippines Inc.	Mega Health Dialysis Center Inc.	Wholly owned subsidiary	Any other transaction	Dividend		NA			213.80	0.00	0.00
176	Nephrocare Health Care Services, Philippines Inc.	People's Center for Hemodialysis Care Inc.	Wholly owned subsidiary	Any other transaction	Dividend		NA			213.80	0.00	0.00
177	Nephrocare Health Care Services, Philippines Inc.	Rizal dialysis and wellness centre OPC	Wholly owned subsidiary	Any other transaction	Dividend		NA			197.00	0.00	0.00
178	Nephrocare Health Care Services, Philippines Inc.	Renal Therapy Solutions Inc	Wholly owned subsidiary	Any other transaction	Dividend		NA			1,068.90	0.00	0.00
179	Nephrocare Health Care Services, Philippines Inc.	St. Margareth Dialysis and Biocare Center Inc.	Wholly owned subsidiary	Any other transaction	Dividend		NA			213.80	0.00	0.00
180	Nephrocare Health Care Services, Philippines Inc.	Universe Dialysis and Kidney Care Center Inc.	Wholly owned subsidiary	Any other transaction	Dividend		NA			397.00	0.00	0.00
181	AIZ Hemodialysis Centre Inc.	Bioregen Hemo Center Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			8.50	0.00	0.00
182	Nephrocare Health Care Services, Philippines Inc.	AIZ Hemodialysis Centre Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			34.00	0.00	0.00
183	Cadiz Dialysis Hub Inc.	Mega Health Dialysis Center Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.20	0.00	0.00
184	Carmona Dialysis System Inc.	Curis Hemodialysis Clinic Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.20	0.00	0.00
185	Infini Care Health Systems Inc.	Bioregen Hemo Center Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			7.10	0.00	0.00
186	Kolff Dialysis Inc.	Bioregen Hemo Center Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			3.60	0.00	0.00
187	Nephro Alliance ventures Inc	Anram Medical Group Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.10	0.00	0.00
188	Nephrocare Health Care Services, Philippines Inc.	Anram Medical Group Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			8.60	0.00	0.00
189	Nephrocare Health Care Services, Philippines Inc.	Bioregen Hemo Center Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			27.50	0.00	0.00
190	Nephrocare Health Care Services, Philippines Inc.	Cadiz Dialysis Hub Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			14.00	0.00	0.00
191	Nephrocare Health Care Services, Philippines Inc.	Carmona Dialysis System Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			30.20	0.00	0.00
192	Nephrocare Health Care Services, Philippines Inc.	Curis Cavite Renal Corporation	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			24.50	0.00	0.00
193	Nephrocare Health Care Services, Philippines Inc.	Curis Hemodialysis Clinic Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			21.30	0.00	0.00
194	Nephrocare Health Care Services, Philippines Inc.	Dialysis Asia and Patient Care Center Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			(3.00)	0.00	0.00
195	Nephrocare Health Care Services, Philippines Inc.	Infini Care Health Systems Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			42.30	0.00	0.00
196	Nephrocare Health Care Services, Philippines Inc.	Kolff Dialysis Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			57.20	0.00	0.00
197	Nephrocare Health Care Services, Philippines Inc.	Medical Experts Group and Associates Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			62.90	0.00	0.00
198	Nephrocare Health Care Services, Philippines Inc.	Mega Health Dialysis Center Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			18.30	0.00	0.00
199	Nephrocare Health Care Services, Philippines Inc.	Nephro Alliance ventures Inc	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			105.50	0.00	0.00
200	Nephrocare Health Care Services, Philippines Inc.	People's Center for Hemodialysis Care Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			32.40	0.00	0.00
201	Nephrocare Health Care Services, Philippines Inc.	Renal Therapy Solutions Inc	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			4.10	0.00	0.00
202	Nephrocare Health Care Services, Philippines Inc.	Rizal dialysis and wellness centre OPC	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			26.90	0.00	0.00
203	Nephrocare Health Care Services, Philippines Inc.	St. Margareth Dialysis and Biocare Center Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			1.00	0.00	0.00
204	Nephrocare Health Care Services, Philippines Inc.	Universe Dialysis and Kidney Care Center Inc.	Wholly owned subsidiary	Any other transaction	Reimbursement of expenses		NA			25.80	0.00	0.00
205	Rizal dialysis and wellness centre OPC	Renal Therapy Solutions Inc	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.10	0.00	0.00
206	Renal Therapy Solutions Inc	Bioregen Hemo Center Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.00	0.00	0.00
207	Renal Therapy Solutions Inc	Carmona Dialysis System Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.00	0.00	0.00
208	AIZ Hemodialysis Centre Inc.	Anram Medical Group Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.20	0.00	0.00
209	AIZ Hemodialysis Centre Inc.	Curis Cavite Renal Corporation	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.20	0.00	0.00
210	AIZ Hemodialysis Centre Inc.	Cadiz Dialysis Hub Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.20	0.00	0.00
211	AIZ Hemodialysis Centre Inc.	Curis Hemodialysis Clinic Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.20	0.00	0.00
212	AIZ Hemodialysis Centre Inc.	Dialysis Asia and Patient Care Center Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.20	0.00	0.00
213	AIZ Hemodialysis Centre Inc.	Medical Experts Group and Associates Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.10	0.00	0.00
214	AIZ Hemodialysis Centre Inc.	Mega Health Dialysis Center Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.10	0.00	0.00
215	AIZ Hemodialysis Centre Inc.	Nephro Alliance ventures Inc	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.10	0.00	0.00
216	AIZ Hemodialysis Centre Inc.	People's Center for Hemodialysis Care Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.20	0.00	0.00
217	AIZ Hemodialysis Centre Inc.	Rizal dialysis and wellness centre OPC	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.30	0.00	0.00
218	AIZ Hemodialysis Centre Inc.	Renal Therapy Solutions Inc	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			1.10	0.00	0.00
219	AIZ Hemodialysis Centre Inc.	Universe Dialysis and Kidney Care Center Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.10	0.00	0.00
220	Curis Cavite Renal Corporation	Curis Hemodialysis Clinic Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.40	0.00	0.00
221	Cadiz Dialysis Hub Inc.	Rizal dialysis and wellness centre OPC	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			1.00	0.00	0.00
222	People's Center for Hemodialysis Care Inc.	Infini Care Health Systems Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.00	0.00	0.00
223	People's Center for Hemodialysis Care Inc.	Kolff Dialysis Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.30	0.00	0.00
224	St. Margareth Dialysis and Biocare Center Inc.	Bioregen Hemo Center Inc.	Fellow subsidiary	Any other transaction	Reimbursement of expenses		NA			0.10	0.00	0.00
225	Nephrocare Health Care Services, Philippines Inc.	Nephro Alliance ventures Inc	Wholly owned subsidiary	Any other transaction	Investment in subsidiary		NA			453.80	0.00	0.00
226	Nephrocare Health Care Services, Philippines Inc.	AIZ Hemodialysis Centre Inc.	Wholly owned subsidiary	Any other transaction	Investment in subsidiary		NA			450.60	0.00	0.00
227	Nephrocare Health Care Services, Philippines Inc.	Bioregen Hemo Center Inc.	Wholly owned subsidiary	Any other transaction	Investment in subsidiary		NA			211.50	0.00	0.00
228	Nephrocare Health Care Services, Philippines Inc.	Carmona Dialysis System Inc.	Wholly owned subsidiary	Any other transaction	Investment in subsidiary		NA			215.30	0.00	0.00
229	Nephrocare Health Care Services, Philippines Inc.	Infini Care Health Systems Inc.	Wholly owned subsidiary	Any other transaction	Investment in subsidiary		NA			266.10	0.00	0.00
230	Nephrocare Health Care Services, Philippines Inc.	Kolff Dialysis Inc.	Wholly owned subsidiary	Any other transaction	Investment in subsidiary		NA			576.40	0.00	0.00
231	Nephrocare Health Care Services, Philippines Inc.	Rizal dialysis and wellness centre OPC	Wholly owned subsidiary	Any other transaction	Investment in subsidiary		NA			58.00	0.00	0.00
232	Nephrocare Health Care Services, Philippines Inc.	Renal Therapy Solutions Inc	Wholly owned subsidiary	Any other transaction	Investment in subsidiary		NA			91.60	0.00	0.00
233	Nephrocare Health Care Services, Philippines Inc.	Curis Hemodialysis Clinic Inc.	Wholly owned subsidiary	Any other transaction	Investment in subsidiary		NA			229.10	0.00	0.00
234	Nephrocare Health Care Services, Philippines Inc.	Curis Cavite Renal Corporation	Wholly owned subsidiary	Any other transaction	Investment in subsidiary		NA			7.60	0.00	0.00
235	Nephrocare Health Services International Pte, Singapore	Nephrocare Health Services Saudi Arabia	Joint venture	Any other transaction	Investment in Subsidiary		NA			914.20	0.00	0.00
236	Nephrocare Health Services International Pte, Singapore	Nephrocare Health Services Saudi Arabia	Joint venture	Any other transaction	Sale of Investement		NA			11.90	0.00	0.00
237	Nephrocare Health Services International Pte, Singapore	Nephrocare Health Services Saudi Arabia	Joint venture	Any other transaction	Loan amount written off		NA			212.80	0.00	0.00
238	Nephrocare Health Care Services, Philippines Inc.	Bioregen Hemo Center Inc.	Wholly owned subsidiary	Any other transaction	Receivables		NA			0.00	17.30	0.00
239	Nephrocare Health Care Services, Philippines Inc.	Carmona Dialysis System Inc.	Wholly owned subsidiary	Any other transaction	Advances/payables		NA			0.00	98.40	1.90
240	Bioregen Hemo Center Inc.	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	8.60	81.50
241	Nephrocare Health Care Services, Philippines Inc.	AIZ Hemodialysis Centre Inc.	Wholly owned subsidiary	Any other transaction	Advances/payables		NA			0.00	74.50	0.00
242	Nephrocare Health Care Services, Philippines Inc.	Curis Hemodialysis Clinic Inc.	Wholly owned subsidiary	Any other transaction	Advances/payables		NA			0.00	132.70	0.00
243	Nephrocare Health Care Services, Philippines Inc.	Infini Care Health Systems Inc.	Wholly owned subsidiary	Any other transaction	Advances/payables		NA			0.00	170.30	23.60
244	Nephrocare Health Care Services, Philippines Inc.	Kolff Dialysis Inc.	Wholly owned subsidiary	Any other transaction	Advances/payables		NA			0.00	151.00	0.00
245	Nephrocare Health Care Services, Philippines Inc.	Nephro Alliance ventures Inc	Wholly owned subsidiary	Any other transaction	Advances/payables		NA			0.00	207.90	146.40
246	AIZ Hemodialysis Centre Inc.	Anram Medical Group Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.20	0.20
247	AIZ Hemodialysis Centre Inc.	Bioregen Hemo Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	8.60
248	AIZ Hemodialysis Centre Inc.	Curis Cavite Renal Corporation	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.20	0.20
249	AIZ Hemodialysis Centre Inc.	Cadiz Dialysis Hub Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	0.20
250	AIZ Hemodialysis Centre Inc.	Curis Hemodialysis Clinic Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.20	0.20
251	AIZ Hemodialysis Centre Inc.	Dialysis Asia and Patient Care Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.20	0.20
252	AIZ Hemodialysis Centre Inc.	Medical Experts Group and Associates Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	0.10
253	AIZ Hemodialysis Centre Inc.	Mega Health Dialysis Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	0.10
254	AIZ Hemodialysis Centre Inc.	Nephro Alliance ventures Inc	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	0.10
255	AIZ Hemodialysis Centre Inc.	People's Center For Hemodialysis Care Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.20	0.20
256	AIZ Hemodialysis Centre Inc.	Rizal Dialysis and Wellness Centre OPC	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.30	0.30
257	AIZ Hemodialysis Centre Inc.	Renal Therapy Solutions INC	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	1.10	1.10
258	Anram Medical Group Inc.	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	211.70	340.10
259	Curis Cavite Renal Corporation	Curis Hemodialysis Clinic Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.40	0.50
260	Curis Cavite Renal Corporation	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	308.40	216.60
261	Cadiz Dialysis Hub Inc.	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	197.40	92.80
262	Carmona Dialysis System Inc.	Bioregen Hemo Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.20	35.20
263	Dialysis Asia and Patient Care Center Inc.	Cadiz Dialysis Hub Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.50	0.50
264	Dialysis Asia and Patient Care Center Inc.	Curis Hemodialysis Clinic Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	0.10
265	Dialysis Asia and Patient Care Center Inc.	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	259.00	165.10
266	Kolff Dialysis Inc.	AIZ Hemodialysis Centre Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	1.00	1.00
267	Medical Experts Group and Associates Inc.	Anram Medical Group Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	0.00
268	Medical Experts Group and Associates Inc.	Cadiz Dialysis Hub Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	1.80	1.80
269	Medical Experts Group and Associates Inc.	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	117.80	90.60
270	Medical Experts Group and Associates Inc.	People's Center For Hemodialysis Care Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	1.00
271	Mega Health Dialysis Center Inc.	Curis Cavite Renal Corporation	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.80	0.80
272	Mega Health Dialysis Center Inc.	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	103.10	138.40
273	People's Center For Hemodialysis Care Inc.	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	123.60	59.60
274	Rizal Dialysis and Wellness Centre OPC	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	64.20	91.30
275	Renal Therapy Solutions INC	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	250.50	984.00
276	St. Margareth Dialysis and Biocare Center Inc.	Bioregen Hemo Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	0.10
277	St. Margareth Dialysis and Biocare Center Inc.	Cadiz Dialysis Hub Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.60	0.60
278	St. Margareth Dialysis and Biocare Center Inc.	Medical Experts Group and Associates Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.80	0.90
279	St. Margareth Dialysis and Biocare Center Inc.	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	238.60	216.90
280	Universe Dialysis and Kidney Care Center Inc.	AIZ Hemodialysis Centre Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.20	0.00
281	Universe Dialysis and Kidney Care Center Inc.	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	282.20	208.20
282	AIZ Hemodialysis Centre Inc.	Carmona Dialysis System Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.60	0.50
283	Anram Medical Group Inc.	Mega Health Dialysis Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	2.60	2.60
284	Anram Medical Group Inc.	People's Center For Hemodialysis Care Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.40	0.70
285	Cadiz Dialysis Hub Inc.	Renal Therapy Solutions INC	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	2.20	0.50
286	Medical Experts Group and Associates Inc.	Mega Health Dialysis Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.20	0.20
287	Medical Experts Group and Associates Inc.	Rizal Dialysis and Wellness Centre OPC	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.00
288	Mega Health Dialysis Center Inc.	St. Margareth Dialysis and Biocare Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.40	0.40
289	Mega Health Dialysis Center Inc.	Universe Dialysis and Kidney Care Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.60	0.90
290	People's Center For Hemodialysis Care Inc.	Renal Therapy Solutions INC	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	0.00
291	Renal Therapy Solutions INC	Anram Medical Group Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.30	0.00
292	St. Margareth Dialysis and Biocare Center Inc.	Dialysis Asia and Patient Care Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.20	0.20
293	St. Margareth Dialysis and Biocare Center Inc.	Anram Medical Group Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	0.10
294	Curis Hemodialysis Clinic Inc.	Bioregen Hemo Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	0.10
295	Universe Dialysis and Kidney Care Center Inc.	Curis Cavite Renal Corporation	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.70	0.70
296	Mega Health Dialysis Center Inc.	Carmona Dialysis System Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	0.20
297	St. Margareth Dialysis and Biocare Center Inc.	Carmona Dialysis System Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.00
298	Anram Medical Group Inc.	Dialysis Asia and Patient Care Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.30	0.30
299	Mega Health Dialysis Center Inc.	Dialysis Asia and Patient Care Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.10	0.10
300	Bioregen Hemo Center Inc.	Infini Care Health Systems Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.60	0.00
301	Curis Hemodialysis Clinic Inc.	Infini Care Health Systems Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.20	0.20
302	Mega Health Dialysis Center Inc.	Kolff Dialysis Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.80	0.90
303	Universe Dialysis and Kidney Care Center Inc.	Kolff Dialysis Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.30	0.30
304	Renal Therapy Solutions INC	Medical Experts Group and Associates Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.80	0.40
305	Anram Medical Group Inc.	Rizal Dialysis and Wellness Centre OPC	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.00
306	Dialysis Asia and Patient Care Center Inc.	Renal Therapy Solutions INC	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.20	0.20
307	Rizal Dialysis and Wellness Centre OPC	Renal Therapy Solutions INC	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.10
308	Infini Care Health Systems Inc.	Carmona Dialysis System Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.20	0.20
309	AIZ Hemodialysis Centre Inc.	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	0.00	0.70
310	AIZ Hemodialysis Centre Inc.	Universe Dialysis and Kidney Care Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.00
311	Anram Medical Group Inc.	Medical Experts Group and Associates Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.60
312	Anram Medical Group Inc.	Renal Therapy Solutions INC	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.40
313	Cadiz Dialysis Hub Inc.	Mega Health Dialysis Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.20
314	Cadiz Dialysis Hub Inc.	Rizal Dialysis and Wellness Centre OPC	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	1.10
315	Curis Hemodialysis Clinic Inc.	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	0.00	352.10
316	Carmona Dialysis System Inc.	Curis Hemodialysis Clinic Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.20
317	Carmona Dialysis System Inc.	Kolff Dialysis Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.60
318	Infini Care Health Systems Inc.	Bioregen Hemo Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	6.10
319	Infini Care Health Systems Inc.	Renal Therapy Solutions INC	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.00
320	Kolff Dialysis Inc.	Bioregen Hemo Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	3.60
321	Kolff Dialysis Inc.	Nephrocare Health Care Services, Philippines Inc.	Holding company	Any other transaction	Advances/payables		NA			0.00	0.00	224.20
322	Mega Health Dialysis Center Inc.	Renal Therapy Solutions INC	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.00
323	Nephro Alliance ventures Inc	Anram Medical Group Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.10
324	People's Center For Hemodialysis Care Inc.	Infini Care Health Systems Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.00
325	People's Center For Hemodialysis Care Inc.	Kolff Dialysis Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.30
326	Renal Therapy Solutions INC	Bioregen Hemo Center Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.00
327	Renal Therapy Solutions INC	Carmona Dialysis System Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.00
328	Renal Therapy Solutions INC	Nephro Alliance ventures Inc	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	0.80
329	Renal Therapy Solutions INC	People's Center For Hemodialysis Care Inc.	Fellow subsidiary	Any other transaction	Advances/payables		NA			0.00	0.00	2.60
Total value of transaction during the reporting period										13,900.70

Sr.	Original Object	Modified Object, if any	Original Allocation	Modified allocation, if any	Funds Utilised	Amount of Deviation/Variation for the quarter according to applicable object	Remarks if any
1	Capital expenditure by the Company for opening new dialysis clinics in India	Nil	12,910.60	0.00	372.20	0.00
2	Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by the Company	Nil	13,599.90	0.00	13,599.90	0.00
3	General corporate purposes	Nil	6,004.80	0.00	2,186.90	0.00
4	Issue expenses	Nil	2,825.20	0.00	1,406.40	0.00

Name of signatory	Kishore Kathri
Designation of person	Company Secretary and Compliance Officer
Place	Hyderabad
Date	19-05-2026

Integrated Filing — IndAS

General information about company

Financial Results Ind-AS

Amount in (Lakhs)

Disclosure of notes on financial results

Remarks

Statement of Asset and Liabilities

Amount in (Lakhs)

Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Other Comprehensive Income

Amount in (Lakhs)

Cash flow statement, indirect

Amount in (Lakhs)

Details of Impact of Audit Qualification

Amount in (Lakhs)

Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Signatory Details

Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)